Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
Kirit Singh, Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, Evanthia Galanis, Michael Lim, Patrick Y. Wen, Giuseppe Minniti, Howard Colman, Timothy F. Cloughesy, Minesh P. Mehta, Marjolein Geurts, Isabel Arrillaga‐Romany, Annick Desjardins, Kirk Tanner, Susan Short, David Arons, Elizabeth S. Duke, Wolfgang Wick, Stephen Bagley, David M. Ashley, Priya Kumthekar, Roel G.W. Verhaak, Anthony J. Chalmers, Anoop P. Patel, Colin Watts, Peter E. Fecci, Tracy T. Batchelor, Michael Weller, Michael A. Vogelbaum, Matthias Preusser, Mitchel S. Berger, Mustafa Khasraw
Topics & Concepts
GlioblastomaDrug discoveryDrug developmentSampling (signal processing)Computer scienceDrugClinical trialMedicineNeuroscienceComputational biologyBioinformaticsPathologyBiologyCancer researchPharmacologyTelecommunicationsDetectorGlioma Diagnosis and Treatment3D Printing in Biomedical ResearchCell Image Analysis Techniques